Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 166.90 EUR | +0.12% |
|
+2.58% | -20.52% |
| 07-28 | SARTORIUS STEDIM BIOTECH : Buy rating from Bernstein | ZD |
| 07-24 | SARTORIUS STEDIM BIOTECH : JP Morgan keeps its Buy rating | ZD |
| Market Cap | 16.22B 18.66B 15.1B 13.86B 26.17B 1,781B 26.58B 178B 69.84B 887B 70.07B 68.53B 2,973B | P/E 2026 * |
43.3x | P/E 2027 * | 33.1x |
|---|---|---|---|---|---|
| Enterprise Value | 18.23B 20.97B 16.97B 15.58B 29.42B 2,002B 29.87B 200B 78.5B 997B 78.76B 77.03B 3,342B | EV / Sales 2026 * |
5.82x | EV / Sales 2027 * | 5.18x |
| Free-Float |
28.47% | Yield 2026 * |
0.49% | Yield 2027 * | 0.62% |
Last Transcript: Sartorius Stedim Biotech
| 1 day | +0.12% | ||
| 1 week | +2.58% | ||
| Current month | +0.12% | ||
| 1 month | -7.38% | ||
| 3 months | +7.33% | ||
| 6 months | -13.07% | ||
| Current year | -20.52% |
| 1 week | 161.2 |  | 174.6 |
| 1 month | 158.9 | | 190.8 |
| Current year | 150 | | 224 |
| 1 year | 150 | | 224 |
| 3 years | 139.1 | | 281 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.13 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/25 | Sell | Company | 750,000 | 0.7706% | ||
| 2/16/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 3/2/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.12% | +2.58% | -1.82% | -38.30% | 18.66B | |
| +0.09% | +2.56% | -16.96% | -2.69% | 183B | |
| -0.37% | +2.62% | -4.42% | -0.08% | 109B | |
| -0.29% | +0.47% | +7.97% | +62.64% | 60.57B | |
| +2.37% | +2.16% | +39.83% | +55.40% | 51.8B | |
| +0.10% | +5.92% | -6.10% | -40.04% | 45.64B | |
| +0.41% | +1.37% | - | - | 33.22B | |
| +11.95% | +16.65% | +5.26% | -32.60% | 31.49B | |
| +0.40% | +3.89% | +42.51% | -7.99% | 24B | |
| -1.22% | +6.69% | +0.67% | +0.26% | 22.26B | |
| Average | +1.36% | +4.03% | +7.44% | -0.38% | 57.98B | |
| Weighted average by Cap. | +0.79% | +3.25% | -0.28% | +4.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.6B 2.91B 2.67B 5.05B 344B 5.13B 34.34B 13.48B 171B 13.52B 13.22B 574B | 3.47B 3.99B 3.23B 2.97B 5.6B 381B 5.69B 38.08B 14.95B 190B 14.99B 14.67B 636B |
| Net income | 376M 433M 350M 322M 607M 41.32B 617M 4.13B 1.62B 20.57B 1.63B 1.59B 68.97B | 480M 553M 447M 411M 775M 52.76B 787M 5.27B 2.07B 26.27B 2.08B 2.03B 88.08B |
| Net Debt | 2.01B 2.31B 1.87B 1.72B 3.24B 221B 3.29B 22.05B 8.66B 110B 8.68B 8.49B 368B | 1.77B 2.03B 1.65B 1.51B 2.85B 194B 2.9B 19.4B 7.61B 96.65B 7.64B 7.47B 324B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-03 | €166.90 | +0.12% | 2,551 |
| 26-07-31 | €166.70 | -2.00% | 137,690 |
| 26-07-30 | €170.10 | -0.64% | 57,064 |
| 26-07-29 | €171.20 | +0.71% | 86,575 |
| 26-07-28 | €170.00 | +4.49% | 102,868 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
